Soreide Law Group is investigating potential claims versus Aegis Capital Corp regarding its sale of Ampio Pharmaceuticals stock to Aegis customers. Aegis was joint booking running manager for Ampio (AMPE) in July 2012 when the company sold additional stock to the public. On the day of the offering the stock traded to a high of 4.25. The stock has trended lower since the sale to the public and is currently trading at .89 per share. Despite years of struggles, Aegis' research department consistently rated the stock as a buy with price projections as high as $15 per share.
If your stock broker recommended AMPE please contact Soreide Law Group for a free legal consultation 1-888-760-6552.
Investors potentially incurred losses because of securities broker Michael Douglass Frost [CRD: 2000358, Colorado Springs, Colorado], based on public information on Financial Industry Regulatory Authority BrokerCheck. Frost worked for LPL Financial LLC from November 29, 2017, to September 18, 2025, and has worked for Cetera Advisors LLC since September 17, 2025. See below to discover […]
Investors potentially incurred losses because of securities broker Chad Anthony Schneider [CRD: 5479256, Greenwood Village, Colorado], according to information disclosed through Financial Industry Regulatory Authority (FINRA) BrokerCheck. Schneider worked for Strong Capital Markets LLC from January 15, 2024, through July 6, 2026. Investors are encouraged to continue reading to find out more about the disclosures […]
Investors might have sustained losses due to financial advisor Ali Reza Memaran-Dadgar [CRD: 5652400, Kirkland, Washington], based on public information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Memaran-Dadgar has been registered with Elite Wealth Management Inc. since February 29, 2024. Continue reading to find out more about the client disputes disclosed on his FINRA record. […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com